Estrella Immunopharma, Inc. Quarterly Assets, Current in USD from Q3 2021 to Q2 2024

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: Estrella Immunopharma, Inc. quarterly Assets, Current history and growth rate from Q3 2021 to Q2 2024.
Estrella Immunopharma, Inc. Assets, Current for the quarter ending June 30, 2024 was $4.45M, a 61.8% increase year-over-year.

Assets, Current, Quarterly (USD)

Assets, Current, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q2 2024	$4.45M	+$1.7M	+61.8%	Jun 30, 2024	10-K	2024-09-27
Q1 2024	$8.63M	+$8.55M	+10443%	Mar 31, 2024	10-Q	2024-05-15
Q4 2023	$9.45M	+$9.39M	+17920%	Dec 31, 2023	10-Q	2024-02-14
Q2 2023	$2.75M	+$2.62M	+2036%	Jun 30, 2023	10-K	2024-09-27
Q1 2023	$81.9K	-$346K	-80.9%	Mar 31, 2023	10-Q	2023-05-18
Q4 2022	$52.4K	-$564K	-91.5%	Dec 31, 2022	10-Q	2023-08-01
Q3 2022	$161K	-$619K	-79.4%	Sep 30, 2022	10-Q	2022-11-14
Q2 2022	$129K			Jun 30, 2022	10-Q	2022-08-08
Q1 2022	$428K			Mar 31, 2022	10-Q	2022-05-16
Q4 2021	$616K			Dec 31, 2021	10-K	2023-03-14
Q3 2021	$780K			Sep 30, 2021	10-Q	2021-11-10

* An asterisk sign (*) next to the value indicates that the value is likely invalid.